ストックスクリーナーアプリを入手
171.56
1.23%
-2.14
プレマーケット:
172.49
0.93
+0.54%
Abbvie Inc (ABBV) 最新ニュース
Guinness Asset Management LTD Increases Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Stokes Capital Advisors LLC Acquires 1,594 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
UMB Bank n.a. Decreases Stock Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Community Bank of Raymore Has $2.47 Million Stock Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Corundum Group Inc. Acquires 4,159 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
3 Unstoppable Dividend-Growth Stocks Yielding More Than 3% That Income-Seeking Investors Want to Buy in 2025 and Hold Forever - The Motley Fool
United States Anesthesia Drugs Research Report 2025: A $3.67 Bn Market by 2033 with Competitive Analysis of Baxter, Abbvie, Medtronic, Draegerwerk, Koninklijke Philips, and Abbott Laboratories - Yahoo Finance
AbbVie Inc. (ABBV): A Bull Case Theory - Insider Monkey
Diversify Advisory Services LLC Sells 6,472 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
Artemis Investment Management LLP Has $85.98 Million Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Brady Martz Wealth Solutions LLC Takes Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat
AbbVie Inc. (NYSE:ABBV) Shares Purchased by Ameritas Advisory Services LLC - MarketBeat
AbbVie Inc. (NYSE:ABBV) Shares Bought by Wealth Alliance Advisory Group LLC - MarketBeat
Jackson Square Capital LLC Reduces Stock Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Cohen Klingenstein LLC Reduces Stock Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Avanza Fonder AB Acquires Shares of 8,443 AbbVie Inc. (NYSE:ABBV) - MarketBeat
AbbVie Inc. (NYSE:ABBV) Short Interest Update - MarketBeat
Why Is AbbVie Inc. (ABBV) Among Louis Navellier’s Top Long-term Stock Picks? - Insider Monkey
AbbVie Inc. (NYSE:ABBV) Position Raised by Lake Street Private Wealth LLC - MarketBeat
AbbVie's SWOT analysis: stock outlook amid Humira erosion and pipeline growth - MSN
Brooklyn Investment Group Has $2.73 Million Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Householder Group Estate & Retirement Specialist LLC Reduces Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Wedge Capital Management L L P NC Trims Stock Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Grant GrossMendelsohn LLC Sells 1,744 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
Channel Wealth LLC Has $1.68 Million Stock Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat
AbbVie Inc. (NYSE:ABBV) Shares Purchased by Yarger Wealth Strategies LLC - MarketBeat
AbbVie Inc. (NYSE:ABBV) Stock Holdings Lifted by KMG Fiduciary Partners LLC - MarketBeat
Deal Dispatch: Biden Punts TikTok Ban To Trump, Plus Another Legacy Retailer Goes Bankrupt - Benzinga
Two more AbbVie drugs put on the Medicare negotiation list - Crain's Chicago Business
AbbVie (ABBV) Benefitted from Top-Line Growth From Its Immunosuppressive Drugs - MSN
Decker Retirement Planning Inc. Purchases New Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat
AbbVie stock target cut, keeps Buy rating on growth outlook - Investing.com
FY2024 Earnings Forecast for AbbVie Issued By Zacks Research - MarketBeat
Tallon Kerry Patrick Buys New Shares in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Mason & Associates Inc Acquires 1,499 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
Giant-Cell Arteritis Pipeline Update 2024: FDA Approvals, Therapeutic Advancements, MOA, ROA, and Developments | AbbVie, Novartis, CSL, Kiniksa Pharma, Eli Lilly, Roche, Johnson & Johnson, MorphoSys - Barchart
Why the Market Dipped But AbbVie (ABBV) Gained Today - Yahoo Finance
AbbVie Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
BMO maintains AbbVie stock Outperform rating - MSN
AbbVie's Quarterly Earnings Preview: What You Need to Know - Nasdaq
Humira Holds Firm at 72% Market Share-AbbVie Fends Off Biosimila - GuruFocus.com
AbbVie and Simcere Join Forces for Multiple Myeloma Breakthrough - Zenopa
Humira Holds Firm at 72% Market Share-AbbVie Fends Off Biosimilar Surge - Yahoo Finance
AbbVie retains Humira market share above 70%: report - MSN
AbbVie retains Humira market share amid biosimilars (ABBV:NYSE) - Seeking Alpha
JPM25 Day 3: AbbVie, Gilead, GSK and Dyne - BioSpace
JPM Day 3: AbbVie, Gilead, GSK and Dyne - PharmaLive
JPM25: The FDA’s future, AbbVie’s second thoughts and Lilly’s lesson - BioPharma Dive
Future Industry Growth Of Antiviral Drugs Market by 2024 To 2031 | AbbVie Inc., GSK plc, Dr. Reddy's - EIN News
AbbVie Inc. (NYSE:ABBV) Shares Purchased by BluePath Capital Management LLC - MarketBeat
Sawyer & Company Inc Sells 3,161 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
Psoriasis Drugs Market Growth Drivers, Revenue, and Size - openPR
Wolff Wiese Magana LLC Acquires 1,750 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
Meyer Handelman Co. Has $27.52 Million Stock Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Radnor Capital Management LLC Has $4.38 Million Stock Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat
AbbVie's Quarterly Earnings Preview: What You Need To Know - Barchart
The Zacks Analyst Blog Highlights Visa, AbbVie, Analog Devices and Precipio - Yahoo Finance
JP Morgan 2025: AbbVie counts on Skyrizi and Rinvoq to fill Humira-sized hole - Yahoo Finance
Top Research Reports for Visa, AbbVie & Analog Devices - Yahoo Finance
Despite $3.5B impairment charge on failed Cerevel drug, AbbVie still sees potential - Crain's Chicago Business
AbbVie Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
AbbVie's $3.5 Billion Blow: Can Bold Bets Revive Its Profit Forecasts? - Yahoo Finance
0.50%
大文字化:
|
ボリューム (24 時間):